A previous study on 57 tumor-paired GBC patients identified that ERBB family and downstream genes is the most common altered pathway in this malignancy, confirming TP53 as the most commonly mutated gene (47.1%) [21]. The gene discussed is EGFR; the disease is neoplasm.